Could a simple shot replace IV drips for tough bone infections?

NCT ID NCT01815541

First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study tested whether giving the antibiotic teicoplanin as a shot under the skin is safe and well-tolerated in adults with bone and joint infections. Thirty patients who were already stable on IV teicoplanin received the subcutaneous version. The main goal was to check for injection-site reactions, not to measure how well the drug fought the infection.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

teicoplanin

What this could lead to

If successful, this could offer a more convenient way to give teicoplanin for bone infections, potentially reducing hospital stays.

What could go wrong

This is a small, early-phase study focused only on safety and local tolerance, not on whether the drug works. Results may not apply to all patients.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OSTEOARTICULAR INFECTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Infections infective arthritis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • CHU Amiens

    Amiens, Picardie, 80054, France